| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Catherine Do | Director | $987,000 | 26 Sep 2025 | ||
| Myron W. Shulgan | Director | $987,000 | 26 Sep 2025 | ||
| Lynn Stockwell | CEO and Exe. Chair of Board, Director, 10%+ Owner | 26 Sep 2025 | |||
| Glenn C. Worman | Cfo | 26 Sep 2025 | |||
| Drugs Made In America Acquisition II LLC | 10%+ Owner | 26 Sep 2025 | |||
| G. Sridhar Prasad | Director | 26 Sep 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Catherine Do | DMII | Ordinary shares | Other | 100,000 | 100,000 | 26 Sep 2025 | Direct | |||
| Myron W. Shulgan | DMII | Ordinary shares | Other | 100,000 | 100,000 | 26 Sep 2025 | Direct | |||
| Glenn C. Worman | DMII | Ordinary shares | Other | 100,000 | 100,000 | 26 Sep 2025 | Direct | |||
| Lynn Stockwell | DMII | Ordinary shares | Sale | -54.3% | -7,966,667 | 6,708,333 | 26 Sep 2025 | See Footnote | ||
| Lynn Stockwell | DMII | Ordinary shares | Other | -2.65% | -400,000 | 14,675,000 | 26 Sep 2025 | See Footnote | ||
| Lynn Stockwell | DMII | Ordinary shares | Purchase | 4.87% | 700,000 | 15,075,000 | 26 Sep 2025 | See Footnote | ||
| Lynn Stockwell | DMII | Rights to receive ordinary shares | Purchase | 700,000 | 700,000 | 26 Sep 2025 | See Footnote | |||
| Drugs Made In America Acquisition II LLC | DMII | Ordinary shares | Sale | -54.3% | -7,966,667 | 6,708,333 | 26 Sep 2025 | Direct | ||
| Drugs Made In America Acquisition II LLC | DMII | Ordinary shares | Other | -2.65% | -400,000 | 14,675,000 | 26 Sep 2025 | Direct | ||
| Drugs Made In America Acquisition II LLC | DMII | Ordinary shares | Purchase | 4.87% | 700,000 | 15,075,000 | 26 Sep 2025 | Direct | ||
| Drugs Made In America Acquisition II LLC | DMII | Rights to receive ordinary shares | Purchase | 700,000 | 700,000 | 26 Sep 2025 | Direct | |||
| G. Sridhar Prasad | DMII | Ordinary shares | Other | 100,000 | 100,000 | 26 Sep 2025 | Direct |